M&A Deal Summary

Sartorius Stedim Biotech Acquires MKS Instruments AB

On April 3, 2017, Sartorius Stedim Biotech acquired software company MKS Instruments AB from MKS Instruments for 73M USD

Acquisition Highlights
  • This is Sartorius Stedim Biotech’s 1st transaction in the Software sector.
  • This is Sartorius Stedim Biotech’s 7th largest (disclosed) transaction.
  • This is Sartorius Stedim Biotech’s 1st transaction in Sweden.

M&A Deal Summary

Date 2017-04-03
Target MKS Instruments AB
Sector Software
Buyer(s) Sartorius Stedim Biotech
Sellers(s) MKS Instruments
Deal Type Divestiture
Deal Value 73M USD

Target

MKS Instruments AB

Malmo, Sweden
MKS Instruments AB (Umetrics) is a provider of data analytics software for modeling and optimizing development and manufacturing processes. SSB has been a cooperation partner of Umetrics since the end of 2012, distributing and co-marketing their software to major players in the biopharmaceutical industry.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sartorius Stedim Biotech

Aubagne, France

Category Company
Founded 1870
Sector Internet Software and Services
Employees10,493
Revenue 816.0B EUR (2023)
DESCRIPTION

Sartorius Stedim Biotech is a provider of cutting edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry. Sartorius Stedim Biotech was founded in 1870 and is based in Aubagne, France.


DEAL STATS #
Overall 11 of 19
Sector (Software) 1 of 1
Type (Divestiture) 2 of 4
Country (Sweden) 1 of 1
Year (2017) 2 of 2
Size (of disclosed) 7 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-03 Essen BioScience

Ann Arbor, Michigan, United States

Essen BioScience, Inc. is a provider of field of cell-based assays and instrumentation used for drug discovery and basic research applications.

Buy $320M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-21 Danaher - Life Science Portfolio

Washington, District of Columbia, United States

Danaher Corp's Life Science Portfolio includes chromatography and SoloHill business. The chromatography business addresses an essential step in downstream bioprocessing and encompasses multi-use and single-use equipment as well as columns and resins. The SoloHill business includes mainly a microcarrier technology and particle validation standards used in cell culture and other bioprocesses.

Buy $750M

Seller(S) 1

SELLER

MKS Instruments

Andover, Massachusetts, United States

Category Company
Founded 1961
Sector Test/Measurement Equipment
Employees10,000
Revenue 3.6B USD (2023)
DESCRIPTION

MKS Instruments is a provider of instruments, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of advanced manufacturing processes to improve process performance and productivity. MKS Instruments was founded in 1961 and is based in Andover, Massachusetts.


DEAL STATS #
Overall 2 of 2
Sector (Software) 1 of 1
Type (Divestiture) 2 of 2
Country (Sweden) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-23 Newport

Irvine, California, United States

Newport Corp. is a supplier of advanced-technology products and systems to customers in the scientific research, microelectronics, life and health sciences, industrial manufacturing and defense/security markets.

Buy $980M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-30 Electro Scientific Industries

Portland, Oregon, United States

Electro Scientific Industries, Inc. is a provider of laser-based manufacturing solutions for the microtechnology industry worldwide. Its laser systems enable precise structuring of micron to submicron features in components and devices, which are used in various end products in the consumer electronics, computer, communications, and other markets. Electro Scientific Industries was founded in 1944 and is based in Portland, Oregon.

Buy $1.0B